Exousia Bio (LMMY) Change in Accured Expenses (2023 - 2025)

Exousia Bio has disclosed Change in Accured Expenses across 3 years of filings, most recently posting $178170.0 for Q4 2025.

• Change in Accured Expenses for Q4 2025 came in at $178170.0, up 7724.77% year-over-year; the trailing twelve-month figure through Nov 2025 was $178246.0 (up 12461.38% YoY), and the FY2025 annual result was -$1211.0, down 301.5% from the prior year.
• Change in Accured Expenses came in at $178170.0 for Q4 2025 at Exousia Bio, up from $3564.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $178170.0 in Q4 2025 to a low of -$2769.0 in Q2 2024.
• The 3-year median for Change in Accured Expenses is $767.0 (2023), against an average of $18173.4.
• Across the five-year window, Change in Accured Expenses tumbled 553.93% in 2024 and jumped 7724.77% in 2025, its largest moves.
• Exousia Bio's Change in Accured Expenses stood at $924.0 in 2023, then soared by 146.43% to $2277.0 in 2024, then surged by 7724.77% to $178170.0 in 2025.
• The last three Change in Accured Expenses figures came in at $178170.0 (Q4 2025), $3564.0 (Q3 2025), and -$1211.0 (Q2 2025), per Business Quant data.